Identification of an activator required for elevation of maturation- promoting factor (MPF) activity by gamma-S-ATP by unknown
Identification of an Activator Required for Elevation of 
Maturation-promoting Factor (MPF) Activity by  ,-S-ATP 
Shigeru Yamashita and James L. Mailer 
Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80262 
Abstract.  Maturation-promoting factor (MPF) is a 
cell cycle control element able to cause cells to enter 
M-phase upon microinjection and will induce 
metaphase in nuclei incubated in cell extracts. Previ- 
ous work has shown that MPF is composed of a com- 
plex between p34  ~dc 2 protein kinase and a  B-type cy- 
clin. In the present work 3,-S-ATP  was found to cause 
activation of MPF activity in partially purified prepa- 
rations, but this activation was lost upon chromatogra- 
phy on Matrex Green gel A. Readdition of other 
Matrex Green fractions to purified MPF restored the 
ability of 3,-S-ATP  to activate MPF for nuclear break- 
down as well as phosphorylation of histone HI.  Use of 
the system described here will facilitate study of 
p34Cdc 2 kinase activation and identification of elements 
involved in MPF regulation. 
M 
ATURATiON-promoting  factor  (MPF) ~ was  first 
described in 1971 as a cytoplasmic activity appear- 
ing during meiosis in amphibian oocytes that could 
cause maturation when injected into resting oocytes, even in 
the absence of protein synthesis (Masui and Markert, 1971; 
Smith and Ecker, 1971). Subsequently, a similar activity was 
found in meiosis and mitosis in other cells, leading to the 
concept that MPF was a universal regulator of M-phase in 
eucaryotic cells (Kishimoto et al.,  1982).  Although MPF 
was believed to be a protein kinase or an activator of a ki- 
nase, little progress was made in its characterization until re- 
cently, with the development of a cell-free system from un- 
fertilized eggs that could carry out early mitotic events in 
vitro (Lohka and Masui,  1983;  Lohka and Mailer,  1985; 
Miake-Lye and Kirschner, 1985).  Using this system, Lohka 
et al. (1988) purified MPF to near homogeneity and showed 
that it consisted of a  32-34-kD  protein kinase complexed 
with a 45-kD substrate. Subsequently, Gautier et al. (1988) 
showed  that the  34-kD  protein  kinase component was  a 
Xenopus homologue of the cdc 2 ÷ gene product, designated 
p34~dc 2, which had been identified in fission yeast as a cru- 
cial regulator of the G2 "-" M  transition in the cell cycle 
(Lee and Nurse,  1988). In addition, Dunphy et al. (1988) found 
that the product of the Schizosacchanomyces  pombe suc I gene, 
which binds p34  cdc 2, blocked MPF action in cell-free ex- 
tracts.  Human p34  ~dc 2 was already known to complement 
mutations in cdc  2 ÷ in fission yeast, demonstrating its im- 
portant function was conserved in mitosis from yeast to man 
(Lee and Nurse,  1987). 
Recently, we demonstrated that the 45-kD component of 
Xenopus MPF was a B-type cyclin, as shown by immunopre- 
cipitation and immunoblotting by specific Xenopus cyclin an- 
1. Abbreviations  used in this paper: MG, Matrex Green; MPF, maturation- 
promoting factor; NEBD, nuclear envelope breakdown. 
tibodies (Gautier et al.,  1990).  MPF from starfish oocytes 
has also been found to be a heterodimer of a B-type cyclin 
with p34  c~ 2 (Labb6 et al.,  1989a).  Cyclins are proteins 
that are continuously synthesized and accumulate during in- 
terphase but that undergo degradation at the metaphase 
anaphase transition (Evans et al.,  1983;  Pines and Hunt, 
1987; Pines and Hunter, 1989).  Cyclins are homologous to 
the cdc 13  ÷ gene in S. pombe, which is required for cdc  2 
kinase activation (Solomon et al.,  1988;  Goebl and Byers, 
1988; Booher and Beach, 1988).  Several investigators have 
found that cell-free extracts of Xenopus eggs are able to syn- 
thesize and degrade cyclin between S- and M-phase. More- 
over, cyclin synthesis alone (Minshull et al., 1989;  Murray 
and Kirschner, 1989) or addition of purified fractions con- 
taining only cyclin (Lohka et al., 1988),  has been reported 
to drive nuclei in extracts into M-phase, and cyclin degrada- 
tion is required for the M  --" S transition (Murray et al., 
1989).  Cyclin is  phosphorylated by  p34  "~c 2 in  the  MPF 
complex (Lohka et al., 1988; Gautier et al., 1988),  and ex- 
ogenous bacterially produced cyclin is a substrate for phos- 
phorylation and thiophosphorylation by purified MPF (Gau- 
tier et al.,  1990).  The thiophosphorylation of cyclin is of 
particular interest because 3,-S-ATP addition to crude frac- 
tions was essential in the purification of Xenopus egg MPF 
(Lohka  et  al.,  1988)  and  Cyert  and  Kirschner  (1988) 
reported that addition of 3,-S-ATP to crude fractions of oo- 
cytes stimulated activation of "pre-MPF, Moreover,  they 
also reported that antibodies to thiophosphate were able to 
deplete partially purified MPF treated with 3,-S-ATP (Cyert 
et al.,  1988).  However,  at present it is not known if the 
thiophosphorylation of cyclin has any functional effect on 
MPE 
At present two different changes in the p34  ~c 2 kinase 
component of MPF have been demonstrated to occur during 
M-phase in different cell types. In HeLa cells, Draetta and 
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of p34  ~dc 2 entered a  high molecular mass complex with a 
62-kD protein and the 13-kD product of the suc I gene. For- 
marion of this complex was associated with elevated protein 
kinase activity, but it is not known if this complex represents 
MPF in HeLa cells. In the budding yeast Saccharomyces 
cerevisiae, a small fraction of the CDC 28 gene product, a 
functional homologue of cdc  2%  enters a  high molecular 
mass complex with a 40-kD substrate and exhibits elevated 
protein kinase activity (Wittenberg and Reed, 1988). It is not 
known if this complex represents MPF in S. cerevisiae. An 
M-phase-activated H1 kinase has also been identified in sev- 
eral cell types as a complex of p34  cac 2 with other proteins 
(Arion et al., 1988; Labb6 et al., 1989b; Langan et al., 1989). 
In addition to association with other components, phos- 
phorylation of p34  ~dc 2 has been identified as a  regulatory 
mechanism controlling its protein kinase activity. Gautier et 
al.  (1989)  showed that in interphase Xenopus oocytes and 
activated eggs, p34  c~c 2 was highly phosphorylated, and its 
histone HI kinase activity was low, whereas upon entry into 
M-phase in either meiosis or mitosis, p34  '~c 2 was dephos- 
phorylated and its histone H1 protein kinase activity became 
activated. Doric and co-workers also reported apparent de- 
phosphorylation of starfish oocyte p34  *ac 2 upon entry into 
M-phase (Labb6 et al., 1989b). The phosphorylation occurs 
on both tyrosine and threonine residues, although quantita- 
tive removal of tyrosine phosphate does not activate mouse 
p34~c  2 (Dunphy and Newport, 1989;  Morla et al.,  1989). 
However,  Gould and Nurse (1989)  identified the phospho- 
tyrosine site in S. pombe cdc 2 and showed mutation in that 
site caused mitotic catastrophe. In both frog and starfish, the 
kinetics of HI kinase activity changes are very similar to 
changes in MPF activity monitored by injection of oocytes. 
During these changes in protein kinase activity of MPF, no 
important change occurs in the amount of p34  '~  2 present 
in the cell (Gautier et al.,  1989; Labb6 et al.,  1989a).  This 
suggests that the disappearance of MPF kinase activity dur- 
ing interphase represents inactivation of the kinase compo- 
nent, not its destruction. 
Consistent with this concept, Dunphy and Newport (1988) 
found that MPF activity could be recovered from ammonium 
sulfate fractions of interphase egg extracts in the presence of 
adenosine  (3'-0-thio)-triphosphate  (7-S-ATP)  and a  small 
amount of crude active MPE In this paper we have inves- 
rigated the activation of MPF by 3,-S-ATP at different stages 
of purification and identified a protein activator required for 
activation by 7-S-ATP. 
Materials and Methods 
Materials 
7-S-ATP and historic HI  were from Boehringer Mannheim  Diagnostics, 
Inc.,  Houston,  TX.  DEAE-Sephacel  and  heparin-Sepharose  were  from 
Pharmacia Inc., Piseataway, NJ, and Matrex Green gel A was from Amicon 
Corp., Danvers, MA. 
Preparation of  Metaphase MPF and Latent MPF 
Metaphase MPF was prepared as described by Lohka et al. (1988) except 
that the heparin-Sepharose column was eluted with 600 mM NaCI instead 
of  400 mM NaCI when 7-S-ATP was omitted from the preparation as indi- 
cated in the figure legends. A unit of MPF is defined as that amount in a 
volume of 50 tzl that causes at least 20% of newly assembled pronuclei to 
undergo nuclear envelope breakdown (NEBD) within 2 h in a final volume 
of 75 #1 containing 2  x  106 sperm nuclei/ml (Lohka et al., 1988). Latent 
MPF was prepared as described by Dunphy and Newport (1988) except that 
eggs were activated by treatment  with the calcium ionophore A23187 (5 
t~g/ml in 50% medium OR2 for 10 rain), followed by washing, and incuba- 
tion in 10% OR2 until 30 min, at which point eggs were crushed by centrifu- 
gation at 10,000 g for 15 min. Pronuclear extracts for assaying MPF were 
prepared as described by Lohka and Mailer (1985). 
Preparation of  Activator Fraction 
The activator fraction was eluted in the 600-1,200 mM NaCI fraction from 
the Matrex Green gel A column used in MPF purification. Proteins in the 
pooled fractions derived from ,~100 ml of eggs were precipitated by addi- 
tion of  an equal volume of  3.8 M ammonium sulfate, collected by centrifuga- 
tion, dissolved in 0.5 ml of  dialysis buffer, and dialyzed overnight. Dialysis 
buffer was 100 mM/5-glycerophosphate, 5 mM EGTA,  15 mM MgCI2, 1 
mM DTT, 20 mM Hepes, pH 7.5. The activator was stored at  -70°C in 
small aliquots. 
Activation of  Latent and Metaphase MPF 
60 #l of  latent MPF was mixed with 3 #1 of  active, metaphase MPF contain- 
ing 1 unit of activity and 3/~1 of 6.6 mM 7-S-ATP. After incubation for 2 h 
at 22°C, MPF activity was assayed as described by Lohka et al.  (1988). 
Controls  were carried  out with 7-S-ATP with latent or metaphase MPF 
alone or latent and metaphase MPF mixed without any 7-S-ATP. Activation 
of metaphase MPF was performed by incubating 18/~1 of Matrex Green- 
purified MPF containing 1 U of activity with 45 V,1 of the activator fraction 
and 3 pl of  6.6 mM 3,-S-ATP for 90 min at 22°C. Controls were carried out 
by incubation of MPF and activator without 3,-S-ATP. MPF activity was 
then assessed under standard conditions as described above. In some experi- 
ments activation mixtures also contained  1 x  l0  s cpm of 7-3sS-ATP and 
the products of the reaction were analyzed by SDS gel electrophoresis and 
autoradiography. H1  histone kinase assays were carried out as described 
previously (Gautier et al.,  1988). 
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Figure 1. Activation of metaphase MPF or latent MPF by 7-S-ATP. 
Latent MPF was isolated as described in Materials and Methods 
from unfertilized eggs activated for 30 min by treatment with the 
calcium ionophore A23187.  Active metaphase MPF was purified 
from nonactivated eggs through ammonium sulfate precipitation by 
the method of Lohka et al. (1988) and diluted to 0.7 U per addition 
so that it alone had no ability to cause NEBD in the absence of  T-S- 
ATP.  Units less than one are depicted as zero in the graph. After 
the indicated components were incubated in a  final volume of 25 
/xl at 22°C for 120 min, various dilutions were added to 12.5 #! of 
cell-free extracts containing newly assembled nuclei and the extent 
of nuclear breakdown assessed by phase contrast and fluorescence 
microscopy. A unit of MPF activity was defined as the reciprocal 
of the highest dilution of MPF that caused at least 20%  of nuclei 
to undergo NEBD. The data show crude active MPF can be further 
activated twofold by 7-S-ATP alone and latent MPF activation re- 
quires both active MPF and 3'-S-ATP. 
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Figure 2. Dose-dependence for metaphase MPF activation of latent 
MPE Different amounts of  metaphase MPF were used in the activa- 
tion of latent MPF as described in Fig. 1. The data show 0.8 U of 
metaphase MPF in combination with ?-S-ATP is sufficient  to cause 
maximal activation of latent MPF. (e) 7-S-ATP plus latent MPF; 
(0) 7-S-ATP alone. 
Results 
In initial investigations, we carried out experiments similar 
to those described by Dunphy and Newport (1988). Ammo- 
nium sulfate fractions were prepared from unfertilized eggs 
in interphase after activation by treatment with the calcium 
ionophore A23187 (latent MPF). These fractions were then 
incubated with 7-S-ATP and a small amount of an ammo- 
nium sulfate fraction of MPF from metaphase-arrested un- 
fertilized  eggs  (active  metaphase  MPF  but  an  amount 
insufficient to cause any NEBD by itself in vitro). After 60 
min, sperm pronuclei assembled in the cell-free system were 
added and NEBD was assessed after an additional 60 min 
by fluorescence microscopy. As reported originally by Dun- 
phy and Newport (1988), we observed elevated MPF activity 
in the cell-free system when these three components were in- 
cubated together (Fig.  1). However, we carried out an addi- 
tional control experiment not reported by Dunphy and New- 
port (1988) and found that 7-S-ATP alone was able to activate 
ammonium-sulfate purified metaphase MPF itself (Fig.  1). 
This indicated that the elevated MPF activity in the system 
reported by Dunphy and Newport (1988) was a mixture of 
effects of 7-S-ATP on the active metaphase MPF component 
itself as well as on the latent MPF component from inter- 
phase eggs. Therefore, subsequent experiments focussed on 
the activation of metaphase MPF from M-phase eggs.  The 
dose dependence of 7-S-ATP-dependent activation of meta- 
phase MPF was compared in the presence and absence of la- 
tent MPF as shown in Fig. 2. Consistent with Fig. 1, substan- 
tial  activation of metaphase  MPF  by 7-S-ATP alone was 
evident at different metaphase MPF concentrations, but maxi- 
mal activation of metaphase MPF by 7-S-ATP occurred at 
higher MPF concentrations than were required for maximal 
activation of latent MPF (Fig. 2). The extent of activation of 
metaphase MPF by 7-S-ATP alone varied considerably from 
one preparation to another, ranging from 1.5- to 4-fold with 
an initial MPF activity of 1 U/50 t~l. 
The metaphase MPF used by Dunphy and Newport (1988) 
and also in Figs. 1 and 2 is a crude ammonium sulfate prepa- 
ration that is <10-fold purified over cytosol. In an attempt to 
analyze the system more rigorously, we have examined the 
activation of metaphase MPF itself in fractions from various 
steps  of  the  MPF  purification  procedure  that  we  have 
reported previously (Lohka et al.,  1988). As shown in Fig. 
3, metaphase MPF purified through TSK3,000SW chroma- 
tography was  no longer able to be activated by 3,-S-ATP 
alone,  although  it would  still  support activation of latent 
MPF from interphase eggs in the presence of 7-S-ATP. Sub- 
sequent experiments demonstrated the activating component 
was  removed at the  Matrex Green chromatography step. 
Whether the latent MPF preparation also contains the ac- 
tivating component removed from metaphase MPF by Ma- 
trex Green chromatography will require purification of the 
latent form of MPF. 
The active metaphase MPF used in Figs. 1-3 was prepared 
according to the procedure of Lohka et al. (1988)  that uses 
addition of 3,-S-ATP to crude extracts and after ammonium 
sulfate precipitation. The 7-S-ATP-dependent activation of 
metaphase MPF in Figs.  1-3 was thus superimposed on a 
preparation that had already been incubated with 7-S-ATP. 
To maximize the effect of 7-S-ATP,  we investigated the acti- 
vation of metaphase MPF in ammonium sulfate preparations 
made without addition of 7-S-ATP. Although the recovery of 
metaphase MPF in such preparations was only 50 % of that 
seen  when  7-S-ATP  was  included,  addition  of 7-S-ATP 
caused a greater increase in MPF activity than when a 7-S- 
ATP incubation had occurred earlier in the purification (data 
not shown). Therefore, subsequent experiments used MPF 
preparations that had not been previously treated with 7-S- 
ATP. The time course of activation of such a metaphase MPF 
preparation and its dependence on 7-S-ATP concentration 
were analyzed, as shown in Fig. 4. The activating effect was 
maximal after 15 min of incubation and ~150/~M 7-S-ATP 
was required for maximal activation. 
Because the component required for activation of MPF 
was separated from MPF by Matrex Green (MG) gel A chro- 
matography (Fig.  3),  we assessed  the ability of fractions 
from the MG column to reconstitute the ability of metaphase 
MG MPF to be activated further by 7-S-ATP.  As shown in 
~10 
0  ~  8 
'~  4 
n 
~0  o  o.- 
0  1 
initial  MPF-activity  (unit/50#l) 
Figure 3.  Removal of an activating component during  MPF  pu- 
rification.  Metaphase  MPF  was  purified  through  TSK3,000SW 
chromatography,  and analyzed for ability to activate latent MPF. 
(e) 7-S-ATP plus latent MPF; (o) ATP-7-S alone. The data show 
the more highly purified MPF is not activated by 7-S-ATP alone 
(compare with Fig. 2) but can still activate latent MPF in the pres- 
ence of 7-S-ATP. 
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Figure 4.  Dependence of metaphase MPF activation on time and 
3,-S-ATE (A) 3,-S-ATP  (300 #M) was mixed with metaphase MPF 
(0.8 U) prepared without 3,-S-ATP for the indicated times at 22°C 
and then MPF activity was assayed in the cell-free system. The data 
show 3,-S-ATP-dependent  activation is maximal by 15 min. (B) 3,-S- 
ATP concentration dependence. Metaphase MPF (0.8 U) was in- 
cubated with varying concentrations of ~/-S-ATP  at 22°C for 2 h and 
then assayed as described in Materials and Methods. The data show 
150/~M "t-S-ATP is sufficient for maximal activation. 
Fig. 5, the 600-1,200 mM eluate of the MG column was able 
to restore the ability of)'-S-ATP to activate active MG MPF, 
but no MPF activity was evident in this fraction alone even 
when incubated with ),-S-ATE 
These results indicate that a thiophosphorylated compo- 
nent is necessary for activation of metaphase MPF. To assess 
whether MPF itself might be thiophosphorylated under these 
conditions, we incubated extracts of M-phase eggs with 3sS- 
)'-SATP or microinjected 35S-3'-S-ATP into oocytes under- 
going germinal vesicle breakdown and analyzed both total 
thiophosphorylation and the level of radiolabel into the 34-kD 
subunit of MPF after immunoprecipitation with the PSTAIR 
antibody against p34  cac z.  Although a  number of proteins 
were labeled in vivo or in vitro with )'-S-ATE after immuno- 
precipitation no  radiotabel  was  detected  in  the  immuno- 
precipitate (data not shown), most likely because thio-ATP 
competes very poorly with ortho-ATP for phosphorylation 
(Erikson and Mailer,  1989). Further analysis of thiophos- 
phorylated proteins was evaluated in assays involving addi- 
tion of 35S-)'-S-ATP to the activator fraction in the presence 
and absence of metaphase MPF. A thiophosphorylated band 
of M, =  45 kD is evident in both the metaphase MPF alone 
and the activator fraction alone, but the number of thiophos- 
phorylated proteins visible when the two fractions are mixed 
is too great to permit identification of specifically enhanced 
thiophosphoproteins (not shown). Purified MPF contains a 
subunit of Mr =  45 kD (Lohka et al., 1988) which has been 
identified as a B-type cyclin and which can be thiophosphor- 
ylated by 7-S-ATP (Gautier et al.,  1990).  Preliminary ex- 
periments indicate that antibody to either cyclin B1 or B2, 
both of which are present in Mono S purified MPF (Gautier 
et al., 1990), can immunoprecipitate a 45-kD thiophosphor- 
ylated band in these extracts (Yamashita, S., and J. Gautier, 
unpublished results). However, under conditions where MPF 
is activated, the amount of radiolabeled thiophosphate in the 
45-kD protein is unchanged. 
These results demonstrate the presence of an activator of 
MPF in the cytoplasm of  metaphase-arrested eggs. This acti- 
vator is necessary for activation of partially purified MPF 
from metaphase-arrested eggs.  The reaction is unlikely to 
represent an autoactivation because no MPF activity was 
evident in the activator fraction in the presence or absence 
of)'-S-ATP, and increasing the amount of MG-purified MPF 
in the system could not substitute for the activator fraction 
(data not shown). Dunphy and Newport (1988) reported and 
we have confirmed here that interphase eggs contain a latent 
form of MPF that conceivably could also be present in the 
activator fraction. To address this possibility, MPF activated 
by )'-S-ATP and the activator was diluted to give the same 
MPF concentration as initially (1  U/50 #1), and then fresh 
activator plus )'-S-ATP was added.  No further increase in 
MPF activity was evident (data not shown), eliminating the 
possibility  that  latent  MPF  was  present  in  the  activator 
fraction. 
Discussion 
Two general approaches to study of the cell cycle have been 
productive to date. One approach has used the power of mo- 
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Figure 5. Loss and restoration of MPF activation by "y-S-ATP.  Ali- 
quots of MPF fractions containing  1 U of activity from various 
stages of purification without initial 3,-S-ATP treatment were in- 
cubated  with  7-S-ATP, and  assayed for activity as  in  Fig.  1. 
Purification from DEAE to MG revealed a loss of  ability to be acti- 
vated. However, readdition of the 0.6-1.2 M eluate from the MG 
column to MG-MPF restored the ability of 7-S-ATP to activate 
MPF (MG-MPF/activator). This material is referred to as the "acti- 
vator" fraction. Incubation of the activator alone with ",/-S-ATP  did 
not produce any MPF activity. 
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genes critical for cell cycle control (see Lee and Nurse, 1988 
for review).  This work has  identified p34  "~c 2 as a central 
regulator involved in the G~ --" M transition  and uncovered 
a network of other cell cycle control genes that regulate cdc 
2 + activity,  including the products of the  wee  1%  nim  1% 
suc  I ÷,  cdc  25%  and  cdc  13  + genes  (RusseU  and  Nurse, 
1987a,  b;  Solomon et al.,  1988;  Goebl and Byers,  1988; 
Hayles et al., 1986; Simanis and Nurse, 1985). A limitation 
to the genetic approach is that it is often difficult to obtain 
the functionally active protein products of the genes.  This 
limitation is absent in the biochemical approach  to the cell 
cycle, which has been used to purify MPF as a major cell 
cycle control element in the G2 ~  M  transition  (Lohka et 
al.,  1988).  Both  the  genetic  and biochemical  approaches 
have converged on MPF in the light of evidence that MPF 
is a complex of p34 ~c 2 and p45 c~ti", homologues of two cell 
cycle control genes identified in yeast. In this paper we have 
continued the biochemical approach to cell cycle control, in- 
vestigating in particular the mechanism of activation of MPE 
We have identified in metaphase MPF an "activator" compo- 
nent that is required for activation of MPF by 3,-S-ATE 
Recent studies have shown that the activation  of MPF by 
the activator  fraction is also correlated with activation  of the 
histone HI  kinase activity of cdc 2, as might be expected. 
In terms of kinase activation,  p34  °.2 kinase activity  in MPF 
has been found by several laboratories to be activated by de- 
phosphorylation during  the cell cycle both  in vivo and in 
vitro (Gautier et al., 1989; Morla et al., 1989; Labbe et al., 
1989a;  Dunphy  and  Newport,  1989;  Gould  and  Nurse, 
1989).  This  biochemical  finding  is  consistent  with  the 
genetic evidence in S. pombe that the function of the cdc 2+ 
gene is inhibited by the product of the wee 1 ÷ gene, which 
is  predicted  to  encode  a  serine/threonine  protein  kinase 
(Russell and Nurse,  1987a). The inhibitory function of this 
gene  is  itself inactivated  by  the  product  of another  gene 
called  nim  1%  which  also  is  predicted  to  encode  a  ser- 
ine/threonine  protein  kinase  (Russell  and  Nurse,  1987b). 
Given the high degree of conservation of mitotic controls it 
is therefore tempting to speculate that the requirement for 
-y-S-ATP for activation  of MPF reflects the irreversible inac- 
tivation  of wee  1 ÷ due to thiophosphorylation by a homo- 
logue of the him 1 + gene. Alternatively, the activator could 
be a p34  cdc z phosphatase that was itself activated  by thio- 
phosphorylation. Finally, the product of the cdc25 ÷ gene is 
involved in the timing of p34 "~ 2 activation and could poten- 
tially be involved here. These possibilities cannot be rigor- 
ously evaluated  until the activator  protein has been purified 
and characterized and the protein kinase that phosphorylates 
it identified. 
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